# Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy

> **NCT02173132** · PHASE3 · COMPLETED · sponsor: **University of Catania** · enrollment: 94 (actual)

## Conditions studied

- Work Stress
- Work Ability
- Work Performance

## Interventions

- **DRUG:** Acetyl-L-carnitine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02173132
- **Lead sponsor:** University of Catania
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2013-11
- **Final completion:** —
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2014-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173132, "Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02173132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*